VieCure vs Veeva Systems
Side-by-side comparison of AI visibility scores, market position, and capabilities
VieCure is an AI-powered precision oncology platform that personalizes cancer treatment plans and manages clinical workflows for oncology providers; integrates molecular data, treatment guidelines, and clinical trial matching;
About
VieCure is an AI health technology company focused on precision oncology, providing a clinical decision support and workflow management platform designed to help oncology providers personalize cancer treatment at the point of care. The company's platform integrates artificial intelligence with real-world oncology data, clinical treatment guidelines (including NCCN guidelines), molecular and genomic profiling results, and clinical trial databases to assist oncologists in identifying the most appropriate therapy for each individual patient based on their specific tumor biology, genetic markers, and clinical history. This moves cancer care toward individualized precision treatment rather than population-level protocol selection.
Veeva Systems (VEEV) reported $2.7B revenue in FY2025, up 14% YoY. #1 cloud platform for life sciences. ~8,000 employees. HQ: Pleasanton, CA. Market cap ~$40B.
About
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executive) and Matt Wallach, Veeva built its platform on Salesforce and later developed its own Vault cloud infrastructure. The company became a public benefit corporation (PBC) in 2021. Veeva reported revenues of $2.7B in fiscal year 2025 (ending January 2025), up 14% year-over-year, with a market capitalization of approximately $40B.
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.